174 Poster - Dissecting the landscape of CAF-mediated drug resistance mechanisms in ALK-rearranged NSCLC.

MLA

Hu, Q., et al. “174 Poster - Dissecting the Landscape of CAF-Mediated Drug Resistance Mechanisms in ALK-Rearranged NSCLC.” European Journal of Cancer, vol. 138, Oct. 2020, p. S48. EBSCOhost, https://doi.org/10.1016/S0959-8049(20)31205-3.

APA

Hu, Q., Rix, L. L. R., Li, X., Welsh, E. A., Fang, B., Yun, S., Kroeger, J., Lawrence, H. R., Marusyk, A., Koomen, J. M., Haura, E. B., & Rix, U. (2020). 174 Poster - Dissecting the landscape of CAF-mediated drug resistance mechanisms in ALK-rearranged NSCLC. European Journal of Cancer, 138, S48. https://doi.org/10.1016/S0959-8049(20)31205-3

Chicago

Hu, Q., L.L. Remsing Rix, X. Li, E.A. Welsh, B. Fang, S. Yun, J. Kroeger, et al. 2020. “174 Poster - Dissecting the Landscape of CAF-Mediated Drug Resistance Mechanisms in ALK-Rearranged NSCLC.” European Journal of Cancer 138 (October): S48. doi:10.1016/S0959-8049(20)31205-3.